Delgado PL, Vázquez MYE

Language: Spanish
References: 23
Page: 112-117
PDF size: 74.27 Kb.

Text Extraction

No abstract.

REFERENCES

1. Mellibovsky L, Díez A. ¿Qué Significa la Calidad Ósea? Seminarios de la Fundación Española de Reumatología. 2006; 7(4): 165-76.

2. Bilezikian JP. Osteoporosis. Endocrinol and Metab Clin of N Am. 2009; 32: 1-321.

3. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med. 1991; 90: 107-110.

4. Conferencia de consenso sobre prevención, diagnóstico y tratamiento de la osteoporosis. Instituto Nacional de la Salud, USA. Rev Esp Enf Metab Oseas. 2000; 9: 231-239.

5. Paisz LG, Rodan GA. Pathogenesis of osteoporosis. Endocr and Metab Clin of N Am. 2009; 32:15-24.

6. Schnatz PF, Marakovits KA, Dubois M, O' Sullivan DM. Osteoporosis screening and treatment guidelines: are they being followed? Menopause, Jul 8. 2011; 18(10): 1072-78.

7. Ferrar L, Roux C, Reid DM, Felsenberg D, Glüer CC, Eastell R. Prevalence of nonfracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study. Osteoporos Int. 2012; 23(3):1035-40.

8. Rostom S, Allali F, Bennani L, Abouqal R, Hajjaj-Hassouni N. The prevalence of vertebral fractures and health-related quality of life in postmenopausal women. Rheumatol Int. 2012; 32(4):971-80.

9. Justin Tortolani P, McCarthy EF, Sponseller PD. Déficit de densidad mineral ósea en niños. J Am Acad Orthop Surg (Ed Esp). 2007; 2: 123-32.

10. Sosa M, Gómez de Tejada MJ, Hernández D. Prevención de la osteoporosis. Concepto, clasificación, factores de riesgo y clínica de la osteoporosis. Rev Esp Enferm Metab Oseas.2010; 10 (Supl A): 7-11.

11. Lei SF, Jiang H, Deng FY, Deng HW. Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect. Osteoporos Int. 2007; 18:1157-75.

12. NIH. Consensus development panel on osteoporosis. Osteoporosis prevention, diagnosis and therapy. JAMA. 2001; 285: 785-95.

13. Worl Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843, Geneve, Switzerland, 1994.

14. Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui L, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med. 2012; 366(3): 225-33.

15. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Modern Rheumatol. 2011; 21(6):608-20.

16. Arrabal-Polo MA, Arrabal MM, de Haro Munoz T, López León VM, Merino Salas S, Ochoa Hortal MA. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int. 2011; 108(11); 1903-8

17. Parfitt AM. What is the normal rate of bone remodeling? Bone. 2009; 35:1-3.

18. Rizzoli R. Atlas of Postmenopausal Osteoporosis. 5th ed. Londres: CMG; 2007.

19. Calderón AM. Los estrógenos y el hueso: revisión de la evidencia. Prog Obstet Ginecol. 2005; 48(2): 79-90.

20. Pérez FR, Cano A, Calaf J, Vázquez F, Ferrer J. Factores reguladores del recambio óseo: estrógenos y vitamina D. Prog Obstet Ginecol. 2009; 52(2): 99-108.

21. Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol. 2011; 7(8): 447-56.

22. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Härkönen P, et al. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology. 2011; 142(12):5371-88.

23. Nakatani Y, Tamaki J, Komatsu M, Iki M, Kajita E. Effect of Distributing an Evidence- Based Guideline for Prevention of Osteoporosis on Health Education Programs in Municipal Health Centers: A Randomized Controlled Trial. J Epidemiol. 2012; 22(2): 103.